Short Interest in Aemetis, Inc (NASDAQ:AMTX) Decreases By 15.3%

Aemetis, Inc (NASDAQ:AMTX) saw a large decline in short interest in March. As of March 13th, there was short interest totaling 4,691,245 shares, a decline of 15.3% from the February 26th total of 5,537,109 shares. Approximately 8.4% of the shares of the stock are sold short. Based on an average daily volume of 1,305,036 shares, the short-interest ratio is currently 3.6 days.

Aemetis Stock Performance

Shares of AMTX stock opened at $3.25 on Tuesday. The stock has a fifty day moving average price of $1.84 and a 200 day moving average price of $1.93. The stock has a market cap of $216.55 million, a PE ratio of -2.44 and a beta of 2.61. Aemetis has a 1 year low of $1.22 and a 1 year high of $3.66.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.04. The firm had revenue of $43.31 million during the quarter, compared to analyst estimates of $72.07 million. As a group, equities research analysts predict that Aemetis will post -2.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

AMTX has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a report on Wednesday, January 21st. Loop Capital set a $1.75 price objective on shares of Aemetis in a report on Thursday, March 12th. Finally, Wall Street Zen raised shares of Aemetis from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Aemetis presently has an average rating of “Hold” and an average price target of $8.25.

Institutional Investors Weigh In On Aemetis

A number of large investors have recently added to or reduced their stakes in AMTX. Creative Planning purchased a new position in Aemetis during the 2nd quarter valued at about $30,000. Engineers Gate Manager LP purchased a new stake in shares of Aemetis in the second quarter valued at about $42,000. Centiva Capital LP acquired a new stake in shares of Aemetis in the third quarter valued at approximately $39,000. Virtu Financial LLC acquired a new stake in shares of Aemetis in the fourth quarter valued at approximately $31,000. Finally, Tower Research Capital LLC TRC increased its stake in shares of Aemetis by 206.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock worth $57,000 after purchasing an additional 15,474 shares in the last quarter. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.